SECsense Logo

Mineralys Therapeutics, Inc. 8-K Report: Key Insights on February 12, 2025

$MLYS
Form 8-K
Filed on: 2025-02-12
Source
Mineralys Therapeutics, Inc. 8-K Report: Key Insights on February 12, 2025

Based on the provided XML data from the financial report, here are the key insights and important information extracted:

  1. Company Identifier:
  • Name: Mineralys Therapeutics, Inc.
  • CIK: 0001933414
  • NASDAQ Ticker: MLYS
  • State of Incorporation: Delaware (DE)
  • IRS Employer Identification Number: 84-1966887
  1. Report Type:
  • Filing Type: Form 8-K (current report)
  1. Filing Date:
  • Date of Filing: February 12, 2025
  1. Business Address:
  • Location: 150 N. Radnor Chester Road, Suite F200, Radnor, PA 19087
  • Contact Number: 888-378-6240
  1. Stock Information:
  • Common Stock: Par value of $0.0001 per share
  1. Period Covered by the Report:
  • Start Date: February 12, 2025
  • End Date: February 12, 2025

Summary:

The report is a Form 8-K filed by Mineralys Therapeutics, Inc., which is a Delaware-based company listed on NASDAQ under the ticker MLYS. The filing date is February 12, 2025, and it pertains to the same date. The company has a par value of $0.0001 per share for its common stock. The address and contact information are also provided for stakeholders.

This information is essential for investors and analysts tracking the company's compliance and operational updates as reported in the 8-K filing.